Several domains of PCAF can act independently or in unison to enable its functions. PCAF has separate acetyltransferase and E3 ubiquitin ligase domains as well as a bromodomain for interaction with other proteins. PCAF also possesses sites for its own acetylation and ubiquitination.
CBP and p300 are large nuclear proteins that bind to many sequence-specific factors involved in cell growth and/or differentiation, including c-jun and the adenoviral oncoprotein E1A. The protein encoded by the PCAF gene associates with p300/CBP. It has in vitro and in vivo binding activity with CBP and p300, and competes with E1A for binding sites in p300/CBP. It has histone acetyl transferase activity with core histones and nucleosome core particles, indicating that this protein plays a direct role in transcriptional regulation.
The acetyltransferase activity and cellular location of PCAF are regulated through acetylation of PCAF itself. PCAF may be autoacetylated (acetylated by itself) or by p300. Acetylation leads to migration to the nucleus and enhances its acetyltransferase activity. PCAF interacts with and is deacetylated by HDAC3, leading to a reduction in PCAF acetyltransferase activity and cytoplasmic localisation.
There are various protein targets of PCAF's acetyltransferase activity including transcription factors such as Fli1, p53 and numerous histone residues. Hdm2, itself a ubiquitin ligase that targets p53, has also been demonstrated to be a target of the ubiquitin-ligase activity of PCAF.
^Lin H, Ting N, Qin J, Lee W (Sep 2003). "M phase-specific phosphorylation of BRCA2 by Polo-like kinase 1 correlates with the dissociation of the BRCA2-P/CAF complex". J. Biol. Chem.278 (38): 35979–87. doi:10.1074/jbc.M210659200. PMID12815053.
^Tini M, Benecke A, Um S, Torchia J, Evans R, Chambon P (Feb 2002). "Association of CBP/p300 acetylase and thymine DNA glycosylase links DNA repair and transcription". Mol. Cell9 (2): 265–77. PMID11864601.
^Chakraborty S, Senyuk V, Sitailo S, Chi Y, Nucifora G (Nov 2001). "Interaction of EVI1 with cAMP-responsive element-binding protein-binding protein (CBP) and p300/CBP-associated factor (P/CAF) results in reversible acetylation of EVI1 and in co-localization in nuclear speckles". J. Biol. Chem.276 (48): 44936–43. doi:10.1074/jbc.M106733200. PMID11568182.
^Soutoglou E, Papafotiou G, Katrakili N, Talianidis I (Apr 2000). "Transcriptional activation by hepatocyte nuclear factor-1 requires synergism between multiple coactivator proteins". J. Biol. Chem.275 (17): 12515–20. PMID10777539.
^Masumi A, Ozato K (Jun 2001). "Coactivator p300 acetylates the interferon regulatory factor-2 in U937 cells following phorbol ester treatment". J. Biol. Chem.276 (24): 20973–80. doi:10.1074/jbc.M101707200. PMID11304541.
^Jin Y, Zeng S, Dai M, Yang X, Lu H (Aug 2002). "MDM2 inhibits PCAF (p300/CREB-binding protein-associated factor)-mediated p53 acetylation". J. Biol. Chem.277 (34): 30838–43. doi:10.1074/jbc.M204078200. PMID12068014.
^Spencer T, Jenster G, Burcin M, Allis C, Zhou J, Mizzen C et al. (Sep 1997). "Steroid receptor coactivator-1 is a histone acetyltransferase". Nature389 (6647): 194–8. doi:10.1038/38304. PMID9296499.
^Kurooka H, Honjo T (Jun 2000). "Functional interaction between the mouse notch1 intracellular region and histone acetyltransferases PCAF and GCN5". J. Biol. Chem.275 (22): 17211–20. doi:10.1074/jbc.M000909200. PMID10747963.
^Bradney C, Hjelmeland M, Komatsu Y, Yoshida M, Yao T, Zhuang Y (Jan 2003). "Regulation of E2A activities by histone acetyltransferases in B lymphocyte development". J. Biol. Chem.278 (4): 2370–6. doi:10.1074/jbc.M211464200. PMID12435739.
^Fuchs M, Gerber J, Drapkin R, Sif S, Ikura T, Ogryzko V et al. (Aug 2001). "The p400 complex is an essential E1A transformation target". Cell106 (3): 297–307. PMID11509179.
^Hamamori Y, Sartorelli V, Ogryzko V, Puri P, Wu H, Wang J et al. (Feb 1999). "Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A". Cell96 (3): 405–13. PMID10025406.
Ott M, Dorr A, Hetzer-Egger C, Kaehlcke K, Schnolzer M, Henklein P et al. (2004). "Tat acetylation: a regulatory switch between early and late phases in HIV transcription elongation.". Novartis Found. Symp. Novartis Foundation Symposia 259: 182–93; discussion 193–6, 223–5. doi:10.1002/0470862637.ch13. ISBN978-0-470-86263-6. PMID15171254.
Peruzzi F (2006). "The multiple functions of HIV-1 Tat: proliferation versus apoptosis". Front. Biosci.11: 708–17. doi:10.2741/1829. PMID16146763.
Stevens M, De Clercq E, Balzarini J (2007). "The regulation of HIV-1 transcription: molecular targets for chemotherapeutic intervention". Med Res Rev26 (5): 595–625. doi:10.1002/med.20081. PMID16838299.
Harrich D, McMillan N, Munoz L, Apolloni A, Meredith L (2007). "Will diverse Tat interactions lead to novel antiretroviral drug targets?". Current drug targets7 (12): 1595–606. doi:10.2174/138945006779025338. PMID17168834.
Yang X, Ogryzko V, Nishikawa J, Howard B, Nakatani Y (1996). "A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A". Nature382 (6589): 319–24. doi:10.1038/382319a0. PMID8684459.
Chen H, Lin R, Schiltz R, Chakravarti D, Nash A, Nagy L et al. (1997). "Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300". Cell90 (3): 569–80. doi:10.1016/S0092-8674(00)80516-4. PMID9267036.
Spencer T, Jenster G, Burcin M, Allis C, Zhou J, Mizzen C et al. (1997). "Steroid receptor coactivator-1 is a histone acetyltransferase". Nature389 (6647): 194–8. doi:10.1038/38304. PMID9296499.
Takeshita A, Cardona G, Koibuchi N, Suen C, Chin W (1997). "TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1". J. Biol. Chem.272 (44): 27629–34. doi:10.1074/jbc.272.44.27629. PMID9346901.
Korzus E, Torchia J, Rose D, Xu L, Kurokawa R, McInerney E et al. (1998). "Transcription factor-specific requirements for coactivators and their acetyltransferase functions". Science279 (5351): 703–7. doi:10.1126/science.279.5351.703. PMID9445475.
Puri P, Sartorelli V, Yang X, Hamamori Y, Ogryzko V, Howard B et al. (1998). "Differential roles of p300 and PCAF acetyltransferases in muscle differentiation". Mol. Cell1 (1): 35–45. doi:10.1016/S1097-2765(00)80005-2. PMID9659901.
Randhawa G, Bell D, Testa J, Feinberg A (1998). "Identification and mapping of human histone acetylation modifier gene homologues". Genomics51 (2): 262–9. doi:10.1006/geno.1998.5370. PMID9722949.
Benkirane M, Chun R, Xiao H, Ogryzko V, Howard B, Nakatani Y et al. (1998). "Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat". J. Biol. Chem.273 (38): 24898–905. doi:10.1074/jbc.273.38.24898. PMID9733796.